Login / Signup

Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals.

Chioma Izzi-EngbeayaWalter DistasoAnjali AminWei YangOluwagbemiga IdowuJulia S KenkreRonak J ShahEvelina WoinChristine ShiNael AlaviHala BedriNiamh BradySophie BlackburnMartina LeczyckaSanya PatelElizaveta SokolEdward Toke-BjolgerudAmbreen QayumMariana Abdel-MalekDavid C D HopeNick S OliverVasiliki BravisShivani MisraTricia Mei-Mei TanNeil E HillVictoria Salem
Published in: BMJ open diabetes research & care (2021)
In this large study of a diverse patient population, comorbidity (ie, diabetes with ischemic heart disease; increasing CFS score in older patients) was a major determinant of poor outcomes with COVID-19. Antiplatelet medication should be evaluated in randomized clinical trials among high-risk patient groups.
Keyphrases
  • coronavirus disease
  • sars cov
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • case report
  • healthcare
  • clinical trial
  • adipose tissue
  • skeletal muscle
  • insulin resistance